• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stepan Reports Fourth Quarter and Full Year 2025 Results

    2/23/26 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $SCL alert in real time by email

    NORTHBROOK, Ill., Feb. 23, 2026 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported:

    Stepan Company Logo (PRNewsfoto/Stepan Company)

    Fourth Quarter 2025 Highlights

    • Reported net income was $5.0 million, up 49% versus the prior year.   Adjusted net income(1) was a $0.5 million loss, down 119% versus the prior year, largely due to higher interest expense, resulting from lower capitalized interest income recognition due to the Pasadena, TX site start-up, a less favorable effective tax rate and lower Surfactant earnings. 
    • EBITDA(2)  was $43.3 million, up 21% versus the prior year.  Adjusted EBITDA(2) was $33.8 million, down 3% year-over-year.
    • Global sales volume was down 3% year-over-year.  Global sales volume, excluding the impact of the Philippines asset divestiture, was flat year-over-year.    
    • Cash from Operations was $60.0 million during the quarter.  Free cash flow(3) for the quarter was $25.4 million, driven by a reduction in working capital.
    • Pre-tax earnings include $6.2 million of goodwill impairment expense related to the Company's Mexican reporting unit and $15.9 million of gains related to the previously announced Philippines and Lake Providence, LA asset divestitures.

    Full Year 2025 Highlights

    • Reported net income was $46.9 million, down 7% versus the prior year.  Adjusted net income(1) was $41.7 million, down 17% versus the prior year.
    • EBITDA(2)  was $208.0 million and Adjusted EBITDA(2) was $198.9 million, up 11% and 6%, respectively, year-over-year.
    • Global sales volume was up 1% year-over-year.  Global sales volume, excluding the impact of the Philippines asset divestiture, was up 2% year-over-year.  

    "2025 was a transformational year for Stepan as we divested two plant sites and completed preliminary work that has positioned us to further optimize our footprint and asset base in 2026.  Despite many challenges in 2025, we delivered growth in several of our core businesses, advanced several strategic initiatives and have an operational plan in place to accelerate profitable growth moving forward.  Full year adjusted EBITDA grew 6% versus prior year despite a significant increase in oleochemical raw material costs and start-up expenses at our Pasadena site.  Volume grew 1%, organic volume grew 2% and net sales were up 7% driven by pricing actions and favorable product and customer mix.  We delivered $25.4 million of free cash flow and increased our dividend for the 58th consecutive year, while reducing our Net Debt by $31.7 million and our Leverage Ratio to 2.5," said Luis E. Rojo, President and Chief Executive Officer.  "Fourth quarter adjusted EBITDA was down 3% primarily due to a challenging North American Surfactant environment.  We continue to recover margins in Surfactants despite an unprecedented run-up in raw material costs.  Polymer volume was up 11% as our Rigid, Specialty Polyols and Phthalic Anhydride businesses all delivered volume growth.  I want to personally thank all of our Stepan colleagues around the world for their hard work and resilience during the year."

    Financial Summary





    Three Months Ended

    December 31,





    Twelve Months Ended

    December 31,



    ($ in thousands, except per share data)



    2025





    2024





    %

    Change





    2025





    2024





    %

    Change



    Net Sales



    $

    553,886





    $

    525,609







    5

    %



    $

    2,332,114





    $

    2,180,274







    7

    %

    Operating Income



    $

    10,502





    $

    7,695







    36

    %



    $

    78,549





    $

    70,480







    11

    %

    Net Income



    $

    5,004





    $

    3,350







    49

    %



    $

    46,895





    $

    50,370







    (7)

    %

    Earnings per Diluted Share



    $

    0.22





    $

    0.15







    47

    %



    $

    2.05





    $

    2.20







    (7)

    %







































    Adjusted Net Income *



    $

    (531)





    $

    2,757







    (119)

    %



    $

    41,680





    $

    50,470







    (17)

    %

    Adjusted Earnings per

       Diluted Share *



    $

    (0.02)





    $

    0.12







    (117)

    %



    $

    1.82





    $

    2.20







    (17)

    %





    * See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share.



     

    Percentage Change in Net Sales

    Net sales in the fourth quarter of 2025 increased 5% year-over-year.  This increase reflects higher selling prices, that were mainly attributable to the pass-through of higher raw material costs and more favorable product mix, and the favorable impact of foreign currency translation.  A 3% decline in sales volume partially offset the above.   





    Three Months Ended

    December 31, 2025





    Twelve Months Ended

    December 31, 2025



    Volume





    (3)

    %





    1

    %

    Selling Price & Mix





    5

    %





    6

    %

    Foreign Translation





    3

    %





    (—)

    %

    Total





    5

    %





    7

    %

             

    Segment Results





    Three Months Ended

    December 31,





    Twelve Months Ended

    December 31,



    ($ in thousands)



    2025





    2024





    %

    Change





    2025





    2024





    %

    Change



    Net Sales





































    Surfactants



    $

    401,832





    $

    378,776







    6

    %



    $

    1,665,983





    $

    1,532,115







    9

    %

    Polymers



    $

    131,682





    $

    129,844







    1

    %



    $

    584,477





    $

    584,905







    (0)

    %

    Specialty Products



    $

    20,372





    $

    16,989







    20

    %



    $

    81,654





    $

    63,254







    29

    %

    Total Net Sales



    $

    553,886





    $

    525,609







    5

    %



    $

    2,332,114





    $

    2,180,274







    7

    %























































    Three Months Ended

    December 31,





    Twelve Months Ended

    December 31,



    ($ in thousands, all amounts pre-tax)



    2025





    2024





    %

    Change





    2025





    2024





    %

    Change



    Operating Income





































    Surfactants



    $

    9,343





    $

    16,173







    (42)

    %



    $

    67,358





    $

    85,618







    (21)

    %

    Polymers



    $

    3,984





    $

    3,396







    17

    %



    $

    43,265





    $

    40,623







    7

    %

    Specialty Products



    $

    5,240





    $

    5,594







    (6)

    %



    $

    25,640





    $

    20,908







    23

    %

    Total Segment

       Operating Income



    $

    18,567





    $

    25,163







    (26)

    %



    $

    136,263





    $

    147,149







    (7)

    %

    Corporate Expenses



    $

    (8,065)





    $

    (17,468)







    (54)

    %



    $

    (57,714)





    $

    (76,669)







    (25)

    %

    Consolidated

       Operating Income



    $

    10,502





    $

    7,695







    36

    %



    $

    78,549





    $

    70,480







    11

    %























































    Three Months Ended

    December 31,





    Year Ended

    December 31,



    ($ in millions)



    2025





    2024





    %

    Change





    2025





    2024





    %

    Change



    EBITDA



    $

    43.3





    $

    35.8







    21

    %



    $

    208.0





    $

    186.9







    11

    %







































    Adjusted EBITDA





































       Surfactants



    $

    32.1





    $

    34.7







    (7)

    %



    $

    153.0





    $

    157.6







    (3)

    %

       Polymers



    $

    12.4





    $

    11.4







    9

    %



    $

    76.4





    $

    73.0







    5

    %

       Specialty Products



    $

    6.7





    $

    7.1







    (6)

    %



    $

    31.5





    $

    26.9







    17

    %

       Unallocated Corporate



    $

    (17.4)





    $

    (18.2)







    (4)

    %



    $

    (62.0)





    $

    (70.5)







    (12)

    %

    Consolidated Adjusted EBITDA



    $

    33.8





    $

    35.0







    (3)

    %



    $

    198.9





    $

    187.0







    6

    %

     

    Consolidated adjusted EBITDA(2) decreased $1.2 million, or 3%, in the quarter.  This decrease was primarily due to a 7% decline in Surfactant sales volume, driven by lower demand in the global commodity Laundry & Cleaning end markets.  Polymer sales volume growth of 11% and lower corporate expenses partially offset the above. 

    • Surfactant net sales were $401.8 million for the quarter, a 6% increase versus the prior year.  Selling prices were up 10% primarily due to pass through of higher raw material costs, improved product and customer mix, along with pricing actions.  Sales volume declined 7% year-over-year primarily due to lower demand within the commodity Laundry & Cleaning end markets, lower demand from our distribution partners and lower volume in the Philippines due to the asset divestiture.  Excluding the impact of the Philippines, organic volume declined 3%.  These declines were partially offset by double digit growth within the Industrial Cleaning end markets and year-over-year growth within the Agricultural and Oilfield end markets.  Foreign currency translation positively impacted net sales by 3%.  Surfactant adjusted EBITDA(2)  for the quarter decreased $2.6 million, or 7%, versus the prior year.  This decrease was primarily due to the 7% decrease in sales volume. 
    • Polymer net sales were $131.7 million for the quarter, a 1% increase versus the prior year.  Selling prices decreased 12%, primarily due to the pass-through of lower raw material costs and competitive pressures.  Sales volume increased 11% in the quarter.  North American Rigid and commodity Phthalic Anhydride sales volume was up double digits year-over-year.  Foreign currency translation positively impacted net sales by 2% during the quarter.  Polymer adjusted EBITDA(2) increased $1.0 million, or 9%, versus the prior year primarily due to the 11% increase in sales volume.    
    • Specialty Products net sales were $20.4 million for the quarter, a 20% increase versus the prior year, primarily due to higher sales volume.  Specialty Products adjusted EBITDA(2) decreased $0.4 million, or 6%.  The decrease in adjusted EBITDA(2) was primarily due to lower margins resulting from order timing fluctuations within the pharmaceutical business.

    Income Taxes

    The Company's effective tax rate was 21.7% in 2025 versus 16.7% in 2024.  This increase was primarily attributable to the non-recurrence of favorable deferred tax adjustments recognized in 2024.

    Outlook

    "As we look forward to 2026, we remain focused on delivering superior shareholder returns with a balanced approach between top line growth and productivity cost out efforts.  Today we announced Project Catalyst, which is a comprehensive plan designed to further optimize our asset base and create a more productive and agile organization to enable growth.  Project Catalyst is expected to deliver approximately $100 million in pre-tax savings over the next two years.  As part of Project Catalyst, Stepan will close its Fieldsboro, NJ site and decommission select assets at its Millsdale, IL and Stalybridge, UK facilities.  Additionally, we are analyzing other opportunities to optimize our asset base, organization structure and operating model.  We will announce future interventions once approved plans are in place,"  said Luis E. Rojo, President and Chief Executive Officer.  "With these actions, we believe we are positioned to deliver full year Adjusted EBITDA growth and positive free cash flow in 2026, despite the ongoing market and tariff uncertainties."

    Notes

    (1) Adjusted net income and adjusted earnings per share are non-GAAP measures which exclude deferred compensation income/expense, certain environmental remediation-related costs as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share.



    (2) EBITDA and adjusted EBITDA are non-GAAP measures.  See Table VI for calculations and GAAP reconciliations of EBITDA and adjusted EBITDA.



    (3) Free cash flow is a non-GAAP measure and reflects cash generated from operations minus capital expenditures.  Cash generated from operations was $60.0 million during the fourth quarter of 2025 and capital expenditures were $34.6 million. 

    Conference Call

    Stepan Company will host a conference call to discuss its third quarter results at 9:00 a.m. ET (8:00 a.m. CT) on February 23, 2026. The call can be accessed by phone and webcast. To access the call by phone, please click on this Registration Link, complete the form and you will be provided with dial in details and a PIN.  To avoid delays, we encourage participants to dial into the conference call ten minutes ahead of the scheduled start time.  The webcast can be accessed through the Investors/Conference Calls page at www.stepan.com. A webcast replay of the conference call will be available at the same location shortly after the call.

    Supporting Slides

    Slides supporting this press release will be made available at www.stepan.com through the Investors/Presentations page at approximately the same time as this press release is issued.

    Corporate Profile

    Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection compounds and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.

    Headquartered in Northbrook, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia. 

    The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com

    More information about Stepan's sustainability program can be found on the Sustainability page at www.stepan.com. 

    Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company's plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company's actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "guidance," "predict," "potential," "continue," "likely," "will," "would," "should," "illustrative" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.

    There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to  accidents, unplanned production shutdowns or disruptions in manufacturing facilities; reduced demand due to customer product reformulations or new technologies; our inability to successfully develop or introduce new products; compliance with laws; our ability to identify suitable acquisition candidates and successfully complete and integrate acquisitions; global competition; volatility of raw material and energy costs and supply; disruptions in transportation or significant changes in transportation costs; downturns in certain industries and general economic downturns; international business risks, including currency exchange rate fluctuations, changes in global trade policies, including tariffs; legal restrictions and taxes; unfavorable resolution of litigation against us; maintaining and protecting intellectual property rights; our ability to access capital markets; global political, military, security or other instability; costs related to expansion or other capital projects; interruption or breaches of information technology systems; our ability to retain executive management and key personnel; and our debt covenants.  In addition to the risks described in the Company's periodic reports, the restructuring actions described herein may involve risks related to the execution of facility closures and asset decommissioning, potential operational disruptions, impacts on employees and local communities, environmental compliance, and the realization of anticipated cost savings and efficiencies.

    These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by applicable laws.

    * * * * *

    Tables follow

    Table I

    STEPAN COMPANY

    For the Three and Twelve Months Ended December 31, 2025 and 2024

    (Unaudited – in 000's, except per share data)







    Three Months Ended

    December 31,





    Twelve Months Ended

    December 31,







    2025





    2024





    2025





    2024



    Net Sales



    $

    553,886





    $

    525,609





    $

    2,332,114





    $

    2,180,274



    Cost of Sales





    502,369







    468,913







    2,062,226







    1,908,060



    Gross Profit





    51,517







    56,696







    269,888







    272,214



    Operating Expenses:

























    Selling





    10,703







    11,018







    48,767







    45,628



    Administrative





    23,710







    24,764







    90,789







    98,277



    Research, Development and Technical Services





    15,703







    13,793







    59,278







    55,674



    Deferred Compensation Expense





    549







    (574)







    2,155







    2,155









    50,665







    49,001







    200,989







    201,734





























    Goodwill Impairment





    6,245







    -







    6,245







    -



    Gain on sale of assets





    (15,895)







    -







    (15,895)



































    Operating Income





    10,502







    7,695







    78,549







    70,480





























    Other Income (Expense):

























    Interest, Net





    (5,689)







    (4,829)







    (22,115)







    (14,182)



    Other, Net





    126







    (410)







    3,470







    4,141









    (5,563)







    (5,239)







    (18,645)







    (10,041)





























    Income Before Provision for Income Taxes





    4,939







    2,456







    59,904







    60,439



    Provision for Income Taxes





    (65)







    (894)







    13,009







    10,069



    Net Income





    5,004







    3,350







    46,895







    50,370



    Net Income Per Common Share

























    Basic



    $

    0.22





    $

    0.15





    $

    2.05





    $

    2.21



    Diluted



    $

    0.22





    $

    0.15





    $

    2.05





    $

    2.20



    Shares Used to Compute Net Income Per

       Common Share

























    Basic





    22,878







    22,841







    22,872







    22,832



    Diluted





    22,891







    22,912







    22,890







    22,931



    Table II

    Reconciliation of Non-GAAP Net Income and Earnings per Diluted Share*







    Three Months Ended

    December 31,





    Twelve Months Ended

    December 31,



    ($ in thousands, except per share amounts)



    2025





    EPS





    2024





    EPS





    2025





    EPS





    2024





    EPS



    Net Income Reported



    $

    5,004





    $

    0.22





    $

    3,350





    $

    0.15





    $

    46,895





    $

    2.05





    $

    50,370





    $

    2.20





















































    Deferred Compensation (Income)



    $

    76





    $

    0.01





    $

    (762)





    $

    (0.03)





    $

    (473)





    $

    (0.02)





    $

    (1,805)





    $

    (0.08)



    Environmental Remediation

        Expense



    $

    65





    $

    0.00





    $

    169





    $

    -





    $

    934





    $

    0.04





    $

    1,905





    $

    0.08



    Goodwill Impairment



    $

    6,245





    $

    0.27





    $

    -





    $

    -





    $

    6,245





    $

    0.27





    $

    -





    $

    -



    Gain on Sale of Assets



    $

    (11,921)





    $

    (0.52)





    $

    -





    $

    -





    $

    (11,921)





    $

    (0.52)





    $

    -





    $

    -



    Adjusted Net Income



    $

    (531)





    $

    (0.02)





    $

    2,757





    $

    0.12





    $

    41,680





    $

    1.82





    $

    50,470





    $

    2.20





    * All amounts in this table are presented after-tax

    The Company believes that certain non-GAAP measures, in conjunction with comparable GAAP measures, are useful for evaluating the Company's operating performance and financial condition.  The Company uses this non-GAAP information as an indicator of business performance and evaluates management's effectiveness with specific reference to these indicators.  Management believes that these non-GAAP financial measures provide useful supplemental information because they exclude non-operational items that affect comparability between years.  These measures should be considered in addition to, not as substitutes for or superior to, measures of financial performance prepared in accordance with GAAP and may differ from similarly titled measures presented by other companies.  The Company's Annual Report on Form 10-K for the year ended December 31, 2024 contains additional information regarding the use of non-GAAP financial measures.

    Summary of Fourth Quarter 2025 Adjusted Net Income Items

    Adjusted net income excludes non-operational deferred compensation income/expense, certain environmental remediation costs and other significant and infrequent or non-recurring items.

    • Deferred Compensation: The fourth quarter of 2025 reported net income includes $0.1 million of after-tax expense versus $0.8 million of after-tax income in the prior year. 
    • Environmental Remediation: The fourth quarter of 2025 reported net income includes $0.1 million of after-tax expense versus $0.2 million of after-tax expense in the prior year.
    • Goodwill Impairment: The fourth quarter of 2025 reported net income includes $6.2 million of after-tax expense related to a goodwill impairment charge taken for the Company's Mexican reporting unit.  There were no impairment charges taken in the prior year.
    • Gain on Sale of Assets: The fourth quarter of 2025 reported net income includes $11.9 million of after-tax income related to the previously announced Philippines and Lake Providence, LA asset sales.

    Table III

    Reconciliation of Pre-Tax to After-Tax Adjustments

    Management uses the non-GAAP adjusted net income metric to evaluate the Company's operating performance.  Management excludes the items listed in the table below because they are non-operational items.  The cumulative tax effect was calculated using the statutory tax rates for the jurisdictions in which the transactions occurred.





    Three Months Ended

    December 31,





    Twelve Months Ended

    December 31,



    ($ in thousands, except per share amounts)



    2025





    EPS





    2024





    EPS





    2025





    EPS





    2024





    EPS



    Pre-Tax Adjustments

















































    Deferred Compensation (Income)



    $

    101











    $

    (1,016)











    $

    (631)











    $

    (2,406)









    Environmental Remediation Expense



    $

    87











    $

    225











    $

    1,245











    $

    2,540









    Goodwill Impairment



    $

    6,245











    $

    -











    $

    6,245











    $

    -









    Gain on Sale of Assets



    $

    (15,895)











    $

    -











    $

    (15,895)











    $

    -









       Total Pre-Tax Adjustments



    $

    (9,462)











    $

    (791)











    $

    (9,036)











    $

    134



























































    Cumulative Tax Effect on Adjustments



    $

    3,927











    $

    198











    $

    3,821











    $

    (34)



























































    After-Tax Adjustments



    $

    (5,535)





    $

    (0.24)





    $

    (593)





    $

    (0.03)





    $

    (5,215)





    $

    (0.23)





    $

    100





    $

    0.00



    Table IV

    Deferred Compensation Plans

    The full effect of the deferred compensation plans on quarterly pre-tax income was $0.1 million of expense versus $1.1 million of income in the prior year.  The quarter-end market prices of Company stock and the impact of deferred compensation on specific income statement line items is summarized below:





    2025





    2024







    12/31





    9/30





    6/30





    3/31





    12/31





    9/30





    6/30





    3/31



    Stepan Company



    $

    47.36





    $

    47.70





    $

    54.58





    $

    55.04





    $

    64.70





    $

    77.25





    $

    83.96





    $

    90.04



     





    Three Months Ended

    December 31,





    Twelve Months Ended

    December 31,



    ($ in thousands)



    2025





    2024





    2025





    2024



    Deferred Compensation

























    Operating Income (Expense)



    $

    (549)





    $

    574





    $

    (2,155)





    $

    (2,155)



    Other, net – Mutual Fund Gain (Loss)





    448







    442







    2,786







    4,561



    Total Pre-Tax



    $

    (101)





    $

    1,016





    $

    631





    $

    2,406



    Total After-Tax



    $

    (76)





    $

    762





    $

    473





    $

    1,805



     

    Effects of Foreign Currency Translation

    The Company's foreign subsidiaries transact business and report financial results in their respective local currencies. These results are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period.  The table below presents the impact that foreign currency translation had on select income statement line items. 

    ($ in millions)



    Three Months Ended

    December 31,





    Change





    Change

    Due to

    Foreign

    Currency

    Translation





    Twelve Months Ended

    December 31,





    Change





    Change

    Due to

    Foreign

    Currency

    Translation







    2025





    2024

















    2025





    2024















    Net Sales



    $

    553.9





    $

    525.6





    $

    28.3





    $

    16.1





    $

    2,332.1





    $

    2,180.3





    $

    151.8





    $

    4.6



    Gross Profit





    51.5







    56.7





    $

    (5.2)







    1.5







    269.9







    272.2





    $

    (2.3)







    (0.4)



    Operating Income





    10.5







    7.7





    $

    2.8







    0.7







    78.5







    70.5





    $

    8.0







    (0.8)



    Pretax Income





    4.9







    2.5





    $

    2.4







    0.5







    59.9







    60.4





    $

    (0.5)







    (1.1)



     





    Corporate Expenses











    Three Months Ended

    December 31,





    Twelve Months Ended

    December 31,



    ($ in thousands)



    2025





    2024





    %

    Change





    2025





    2024





    %

    Change



    Total Corporate Expenses



    $

    8,065





    $

    17,468







    (54)

    %



    $

    57,714





    $

    76,669







    (25)

    %

    Less:





































       Deferred Compensation Expense



    $

    549





    $

    (574)







    (196)

    %



    $

    2,155





    $

    2,155







    (—)

    %

       Environmental Remediation

          Expense



    $

    87





    $

    225







    (61)

    %



    $

    1,245





    $

    2,540







    (51)

    %

      Goodwill Impairment



    $

    6,245





    $

    -





    NM





    $

    6,245





    $

    -





    NM



      Gain on Sale of Assets



    $

    (15,895)





    $

    -





    NM





    $

    (15,895)





    $

    -





    NM



    Adjusted Corporate Expenses



    $

    17,079





    $

    17,817







    (4)

    %



    $

    63,964





    $

    71,974







    (11)

    %

    Adjusted Corporate expenses decreased $0.7 million, or 4% for the quarter.  This decrease was primarily due to the non-recurrence of CEO transition expenses in the fourth quarter of 2024.

    Table V

    Stepan Company

    Consolidated Balance Sheets

    December 31, 2025 and December 31, 2024







    December 31, 2025





    December 31, 2024



    ASSETS













    Current Assets



    $

    858,959





    $

    810,429



    Property, Plant & Equipment, Net





    1,219,627







    1,198,454



    Other Assets





    279,116







    295,765



    Total Assets



    $

    2,357,702





    $

    2,304,648



    LIABILITIES AND STOCKHOLDERS' EQUITY     













    Current Liabilities



    $

    666,494





    $

    669,034



    Deferred Income Taxes





    11,450







    9,612



    Long-term Debt





    340,975







    332,632



    Other Non-current Liabilities





    94,773







    123,436



    Total Stepan Company Stockholders' Equity





    1,244,010







    1,169,934



    Total Liabilities and Stockholders' Equity



    $

    2,357,702





    $

    2,304,648



     

    Selected Balance Sheet Information 

    The Company's total debt decreased by $28.8 million and cash increased by $14.2 million versus September 30, 2025.  The Company's net debt level decreased $43.0 million versus September 30, 2025 and the net debt ratio was 28% versus 30% in the prior quarter (Net Debt and Net Debt Ratio are non-GAAP measures, reconciliations of which are shown in the table below).  Management uses the non-GAAP net debt metric to show a more complete picture of the Company's overall liquidity, financial flexibility and leverage level. 

    ($ in millions)

    December 31,

    2025





    September 30,

    2025





    June 30,

    2025





    March 31,

    2025





    December 31,

    2024



    Net Debt





























    Total Debt

    $

    626.7





    $

    655.5





    $

    658.0





    $

    659.3





    $

    625.4



    Cash



    132.7







    118.5







    88.9







    107.5







    99.7



    Net Debt

    $

    494.0





    $

    537.0





    $

    569.1





    $

    551.8





    $

    525.7



    Equity



    1,244.0







    1,246.8







    1,241.7







    1,200.5







    1,169.9



    Net Debt + Equity

    $

    1,738.0





    $

    1,783.8





    $

    1,810.8





    $

    1,752.3





    $

    1,695.6



    Net Debt / (Net Debt + Equity)     



    28

    %





    30

    %





    31

    %





    31

    %





    31

    %

     

    The major working capital components were:

    ($ in millions)

    December 31,

    2025





    September 30,

    2025





    June 30,

    2025





    March 31,

    2025





    December 31,

    2024



    Net Receivables

    $

    388.0





    $

    436.1





    $

    442.2





    $

    436.5





    $

    388.0



    Inventories



    298.8







    324.3







    329.5







    309.3







    288.7



    Accounts Payable     



    (261.7)







    (289.4)







    (281.8)







    (298.1)







    (258.8)





    $

    425.1





    $

    471.0





    $

    489.9





    $

    447.7





    $

    417.9



    Table VI

    Reconciliations of Non-GAAP EBITDA and Adjusted EBITDA

    Management uses the non-GAAP EBITDA and adjusted EBITDA metrics to evaluate the Company's operating performance.  Management excludes the items listed in the table below because they are non-operational items.  Refer to the Income Statement on Table I for a bridge between Operating Income and Net Income.





    Three Months Ended

    December 31, 2025

































    ($ in millions)



    Surfactants





    Polymers





    Specialty

    Products





    Unallocated

    Corporate





    Consolidated



    Operating Income



    $

    9.4





    $

    4.0





    $

    5.2





    $

    (8.1)





    $

    10.5



       Depreciation and Amortization     





    22.7







    8.4







    1.5







    0.1







    32.7



       Other, Net Income





    -







    -







    -







    0.1







    0.1



    EBITDA



























    $

    43.3



       Deferred Compensation





    -







    -







    -







    0.1







    0.1



       Environmental Remediation





    -







    -







    -







    0.1







    0.1



       Goodwill Impairment





    -







    -







    -







    6.2







    6.2



       Gain on Sale of Assets





    -







    -







    -







    (15.9)







    (15.9)



    Adjusted EBITDA



    $

    32.1





    $

    12.4





    $

    6.7





    $

    (17.4)





    $

    33.8







































    Three Months Ended

    December 31, 2024



































    ($ in millions)



    Surfactants





    Polymers





    Specialty

    Products





    Unallocated

    Corporate





    Consolidated



    Operating Income



    $

    16.2





    $

    3.4





    $

    5.6





    $

    (17.5)





    $

    7.7



       Depreciation and Amortization





    18.5







    8.0







    1.5







    0.5







    28.5



       Other, Net Income





    -







    -







    -







    (0.4)







    (0.4)



    EBITDA



























    $

    35.8



       Deferred Compensation





    -







    -







    -







    (1.0)







    (1.0)



       Environmental Remediation





    -







    -







    -







    0.2







    0.2



    Adjusted EBITDA



    $

    34.7





    $

    11.4





    $

    7.1





    $

    (18.2)





    $

    35.0

















































    Twelve Months Ended

    December 31, 2025



































    ($ in millions)



    Surfactants





    Polymers





    Specialty

    Products





    Unallocated

    Corporate





    Consolidated



    Operating Income



    $

    67.4





    $

    43.3





    $

    25.6





    $

    (57.8)





    $

    78.5



       Depreciation and Amortization





    85.6







    33.1







    5.9







    1.4







    126.0



       Other, Net Income





    -







    -







    -







    3.5







    3.5



    EBITDA



























    $

    208.0



       Deferred Compensation





    -







    -







    -







    (0.6)







    (0.6)



       Environmental Remediation





    -







    -







    -







    1.2







    1.2



       Goodwill Impairment





    -







    -







    -







    6.2







    6.2



       Gain on Sale of Assets





    -







    -







    -







    (15.9)







    (15.9)



    Adjusted EBITDA



    $

    153.0





    $

    76.4





    $

    31.5





    $

    (62.0)





    $

    198.9







































    Twelve Months Ended

    December 31, 2024



































    ($ in millions)



    Surfactants





    Polymers





    Specialty

    Products





    Unallocated

    Corporate





    Consolidated



    Operating Income



    $

    85.6





    $

    40.6





    $

    20.9





    $

    (76.6)





    $

    70.5



       Depreciation and Amortization





    72.0







    32.4







    6.0







    1.9







    112.3



       Other, Net Income





    -







    -







    -







    4.1







    4.1



    EBITDA



























    $

    186.9



       Deferred Compensation





    -







    -







    -







    (2.4)







    (2.4)



       Environmental Remediation





    -







    -







    -







    2.5







    2.5



    Adjusted EBITDA



    $

    157.6





    $

    73.0





    $

    26.9





    $

    (70.5)





    $

    187.0



     

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/stepan-reports-fourth-quarter-and-full-year-2025-results-302694000.html

    SOURCE Stepan Company

    Get the next $SCL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SCL

    DatePrice TargetRatingAnalyst
    1/23/2026$75.00Neutral → Buy
    Seaport Research Partners
    10/19/2023$89.00Neutral → Buy
    CL King
    3/11/2022$9.00 → $8.00Outperform
    RBC Capital
    12/20/2021$8.50 → $9.00Outperform
    RBC Capital
    More analyst ratings

    $SCL
    SEC Filings

    View All

    Stepan Company filed SEC Form 8-K: Regulation FD Disclosure

    8-K - STEPAN CO (0000094049) (Filer)

    2/23/26 7:05:21 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan Company filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - STEPAN CO (0000094049) (Filer)

    2/23/26 7:00:26 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 8-K filed by Stepan Company

    8-K - STEPAN CO (0000094049) (Filer)

    11/28/25 4:10:36 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Stepan Reports Fourth Quarter and Full Year 2025 Results

    NORTHBROOK, Ill., Feb. 23, 2026 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: Fourth Quarter 2025 HighlightsReported net income was $5.0 million, up 49% versus the prior year.   Adjusted net income(1) was a $0.5 million loss, down 119% versus the prior year, largely due to higher interest expense, resulting from lower capitalized interest income recognition due to the Pasadena, TX site start-up, a less favorable effective tax rate and lower Surfactant earnings. EBITDA(2)  was $43.3 million, up 21% versus the prior year.  Adjusted EBITDA(2) was $33.8 million, down 3%

    2/23/26 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan Declares Quarterly Dividend

    NORTHBROOK, Ill., Feb. 23, 2026 /PRNewswire/ -- Stepan Company (NYSE: SCL) today reported: The Board of Directors of Stepan Company has declared a quarterly cash dividend on the Company's common stock of $0.395 per share. The dividend is payable on March 13, 2026, to common stockholders of record on March 2, 2026. The Company increased its quarterly cash dividend in the fourth quarter of 2025 by $0.010 per share, marking the 58th consecutive year that the Company has increased its cash dividend to stockholders.Corporate ProfileStepan Company is a major manufacturer of specialty

    2/23/26 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan Company Announces $100 Million Pre-Tax Cost Out and Efficiency Plan to Support Global Operations Optimization

    NORTHBROOK, Ill., Feb. 23, 2026 /PRNewswire/ -- Stepan Company (NYSE:SCL) today announced Project Catalyst, a comprehensive operational and efficiency plan with the objective to deliver approximately $100 million in pre-tax savings over the next two years. Project Catalyst is a key part of Stepan's commitment to optimizing its global manufacturing footprint, driving shareholder returns and building a foundation for sustainable growth. Key elements of the plan include:Optimizing Stepan's global manufacturing footprint through consolidation of volume into more efficient and modern

    2/23/26 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: President & CEO Rojo Luis exercised 683 shares at a strike of $66.39 and covered exercise/tax liability with 237 shares, increasing direct ownership by 3% to 15,641 units (SEC Form 4)

    4/A - STEPAN CO (0000094049) (Issuer)

    2/19/26 8:27:11 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    V.P. and Gen'l. Mgr., Polymers Stepan Richard Finn exercised 341 shares at a strike of $66.39 and covered exercise/tax liability with 118 shares, increasing direct ownership by 0.09% to 241,339 units (SEC Form 4)

    4 - STEPAN CO (0000094049) (Issuer)

    2/19/26 8:14:26 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    VP & GM Surfactants Moriarty Sean Thomas exercised 455 shares at a strike of $66.39 and covered exercise/tax liability with 158 shares, increasing direct ownership by 2% to 14,145 units (SEC Form 4)

    4 - STEPAN CO (0000094049) (Issuer)

    2/19/26 8:00:14 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lewis Susan bought $31,765 worth of shares (500 units at $63.53), increasing direct ownership by 36% to 1,896 units (SEC Form 4)

    4 - STEPAN CO (0000094049) (Issuer)

    2/27/25 8:57:39 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    VP GC & Secretary Kabbes David bought $75,388 worth of shares (1,056 units at $71.39) (SEC Form 4)

    4 - STEPAN CO (0000094049) (Issuer)

    8/15/24 1:19:55 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stepan Company upgraded by Seaport Research Partners with a new price target

    Seaport Research Partners upgraded Stepan Company from Neutral to Buy and set a new price target of $75.00

    1/23/26 8:12:18 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan Company upgraded by CL King with a new price target

    CL King upgraded Stepan Company from Neutral to Buy and set a new price target of $89.00

    10/19/23 9:02:32 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    RBC Capital reiterated coverage on Shawcor with a new price target

    RBC Capital reiterated coverage of Shawcor with a rating of Outperform and set a new price target of $8.00 from $9.00 previously

    3/11/22 7:14:07 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Leadership Updates

    Live Leadership Updates

    View All

    Stepan Announces Appointment of New Vice President and Chief Financial Officer

    NORTHBROOK, Ill., July 14, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) announced today the appointment of Ruben Velasquez as Vice President and Chief Financial Officer of Stepan, effective as of July 15, 2025. Mr. Velasquez will succeed Samuel Hinrichsen who, as previously reported, is presently serving as Vice President and Interim Chief Financial Officer. Mr. Hinrichsen will continue in his role as Vice President of Finance. Mr. Velasquez most recently served as Vice President Global Finance Transformation at 3M Company. Prior to that, Mr. Velasquez held several senior fi

    7/14/25 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan Company Announces Appointment of New Director

    NORTHBROOK, Ill., June 9, 2025 /PRNewswire/ -- Stepan Company (NYSE: SCL) announced today the appointment of Corning Painter as a Director of Stepan, effective immediately. Mr. Painter currently serves as Chief Executive Officer of Orion S.A., a global chemical manufacturer, a role he has held since September of 2018. Prior to joining Orion, Mr. Painter was an Executive Vice President for Industrial Gases at Air Products and Chemicals, an industrial gas company, which Mr. Painter joined in 1984. Mr. Painter is a Certified Professional Engineer and holds a chemical engineering

    6/9/25 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan Promotes Luis E. Rojo to President and Chief Executive Officer

    NORTHBROOK, Ill., Oct. 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today announced the appointment of Luis E. Rojo as President and Chief Executive Officer and as a member of the Board of Directors, effective immediately. After a 31-year Stepan career, Scott R. Behrens is departing the Company to pursue other opportunities. "We thank Scott for his leadership and his many contributions to the growth and diversification of Stepan over his career with the Company. During his various roles in R&D, sales and marketing, and leadership, he helped diversify our market presence,

    10/30/24 6:55:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Stepan Company

    SC 13G - STEPAN CO (0000094049) (Subject)

    2/9/24 9:59:18 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Stepan Company (Amendment)

    SC 13G/A - STEPAN CO (0000094049) (Subject)

    1/24/24 12:33:12 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Stepan Company (Amendment)

    SC 13G/A - STEPAN CO (0000094049) (Subject)

    1/22/24 3:52:11 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Financials

    Live finance-specific insights

    View All

    Stepan Reports Fourth Quarter and Full Year 2025 Results

    NORTHBROOK, Ill., Feb. 23, 2026 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: Fourth Quarter 2025 HighlightsReported net income was $5.0 million, up 49% versus the prior year.   Adjusted net income(1) was a $0.5 million loss, down 119% versus the prior year, largely due to higher interest expense, resulting from lower capitalized interest income recognition due to the Pasadena, TX site start-up, a less favorable effective tax rate and lower Surfactant earnings. EBITDA(2)  was $43.3 million, up 21% versus the prior year.  Adjusted EBITDA(2) was $33.8 million, down 3%

    2/23/26 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan Declares Quarterly Dividend

    NORTHBROOK, Ill., Feb. 23, 2026 /PRNewswire/ -- Stepan Company (NYSE: SCL) today reported: The Board of Directors of Stepan Company has declared a quarterly cash dividend on the Company's common stock of $0.395 per share. The dividend is payable on March 13, 2026, to common stockholders of record on March 2, 2026. The Company increased its quarterly cash dividend in the fourth quarter of 2025 by $0.010 per share, marking the 58th consecutive year that the Company has increased its cash dividend to stockholders.Corporate ProfileStepan Company is a major manufacturer of specialty

    2/23/26 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan to Announce Fourth Quarter 2025 Results on February 23, 2026

    NORTHBROOK, Ill., Feb. 3, 2026 /PRNewswire/ -- Stepan Company (NYSE:SCL) will issue its fourth quarter 2025 earnings results on Monday, February 23, 2026 at approximately 7:00 a.m. ET (6:00 a.m. CT). Supporting slides will be posted at approximately the same time on the Investors/Presentations page at www.stepan.com. The Company will hold a conference call to discuss and answer questions about its financial and operational performance on the same day at 9:00 a.m. ET (8:00 a.m. CT). The call will be hosted by Luis E. Rojo, President and Chief Executive Officer, and Ruben D. Vel

    2/3/26 4:01:00 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary